Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Prostate Cancer

  Free Subscription

Articles published in Magn Reson Imaging

Retrieve available abstracts of 27 articles:
HTML format

Single Articles

    June 2021
  1. ZHANG KS, Schelb P, Kohl S, Radtke JP, et al
    Improvement of PI-RADS-dependent prostate cancer classification by quantitative image assessment using radiomics or mean ADC.
    Magn Reson Imaging. 2021;82:9-17.
    PubMed     Abstract available

    April 2021
  2. BOSCHHEIDGEN M, Schimmoller L, Kasprowski L, Abrar D, et al
    Arterial spin labelling as a gadolinium-free alternative in the detection of prostate cancer.
    Magn Reson Imaging. 2021 Apr 24. pii: S0730-725X(21)00068.
    PubMed     Abstract available

    December 2020
  3. WANG Y, Tadimalla S, Rai R, Goodwin J, et al
    Quantitative MRI: Defining repeatability, reproducibility and accuracy for prostate cancer imaging biomarker development.
    Magn Reson Imaging. 2020 Dec 31. pii: S0730-725X(20)30672.
    PubMed     Abstract available

  4. AKAMINE Y, Ueda Y, Ueno Y, Sofue K, et al
    Application of hierarchical clustering to multi-parametric MR in prostate: Differentiation of tumor and normal tissue with high accuracy.
    Magn Reson Imaging. 2020;74:90-95.
    PubMed     Abstract available

    August 2020
  5. PARK S, Park JG, Jun S, Kim H, et al
    Differentiation of bone metastases from prostate cancer and benign red marrow depositions of the pelvic bone with multiparametric MRI.
    Magn Reson Imaging. 2020 Aug 26. pii: S0730-725X(19)30749.
    PubMed     Abstract available

    December 2019
  6. GIGANTI F, Pecoraro M, Fierro D, Campa R, et al
    DWI and PRECISE criteria in men on active surveillance for prostate cancer: A multicentre preliminary experience of different ADC calculations.
    Magn Reson Imaging. 2019;67:50-58.
    PubMed     Abstract available

    September 2019
  7. IKOMA Y, Kishimoto R, Tachibana Y, Omatsu T, et al
    Reference region extraction by clustering for the pharmacokinetic analysis of dynamic contrast-enhanced MRI in prostate cancer.
    Magn Reson Imaging. 2019 Sep 2. pii: S0730-725X(19)30209.
    PubMed     Abstract available

    August 2019
  8. BRUNESE L, Mercaldo F, Reginelli A, Santone A, et al
    Formal Methods for Prostate Cancer Gleason Score and Treatment Prediction using Radiomic Biomarkers.
    Magn Reson Imaging. 2019 Aug 30. pii: S0730-725X(19)30243.
    PubMed     Abstract available

    July 2019
  9. MCNABB E, Wong R, Noseworthy MD
    Differentiating platinum coated brachytherapy seeds and gold fiducial markers with varying off-resonant frequency offsets.
    Magn Reson Imaging. 2019;60:68-75.
    PubMed     Abstract available

    March 2019
  10. WANG Y, Yu B, Zhong F, Guo Q, et al
    MRI-based texture analysis of the primary tumor for pre-treatment prediction of bone metastases in prostate cancer.
    Magn Reson Imaging. 2019 Mar 24. pii: S0730-725X(18)30561.
    PubMed     Abstract available

    February 2019
  11. GIGANTI F, Stabile A, Giona S, Marenco J, et al
    Prostate cancer treated with irreversible electroporation: MRI-based volumetric analysis and oncological outcome.
    Magn Reson Imaging. 2019 Feb 12. pii: S0730-725X(18)30646.
    PubMed     Abstract available

    January 2019
  12. OGURA A, Maeda F, Yahata S, Koyama D, et al
    Slow component apparent diffusion coefficient for prostate cancer: Comparison and correlation with pharmacokinetic evaluation from dynamic contrast-enhanced MR imaging.
    Magn Reson Imaging. 2019 Jan 7. pii: S0730-725X(18)30524.
    PubMed     Abstract available

    October 2018
  13. GIGANTI F, Allen C, Piper JW, Mirando D, et al
    Sequential prostate MRI reporting in men on active surveillance: initial experience of a dedicated PRECISE software program.
    Magn Reson Imaging. 2018 Oct 20. pii: S0730-725X(18)30335.
    PubMed     Abstract available

    August 2018
  14. MAZAHERI Y, Shukla-Dave A, Goldman DA, Moskowitz CS, et al
    Characterization of prostate cancer with MR spectroscopic imaging and diffusion-weighted imaging at 3Tesla.
    Magn Reson Imaging. 2018 Aug 31. pii: S0730-725X(18)30428.
    PubMed     Abstract available

    June 2018
  15. ZIAYEE F, Muller-Lutz A, Gross J, Quentin M, et al
    Influence of arterial input function (AIF) on quantitative prostate dynamic contrast-enhanced (DCE) MRI and zonal prostate anatomy.
    Magn Reson Imaging. 2018 Jun 11. pii: S0730-725X(18)30212.
    PubMed     Abstract available

    April 2018
  16. MAZAHERI Y, Hotker AM, Shukla-Dave A, Akin O, et al
    Effect of intravascular contrast agent on diffusion and perfusion fraction coefficients in the peripheral zone and prostate cancer.
    Magn Reson Imaging. 2018 Apr 17. pii: S0730-725X(18)30056.
    PubMed     Abstract available

  17. ERTAS G
    Detection of high GS risk group prostate tumors by diffusion tensor imaging and logistic regression modelling.
    Magn Reson Imaging. 2018 Apr 9. pii: S0730-725X(18)30050.
    PubMed     Abstract available

    January 2018
  18. KIM H
    Modification of population based arterial input function to incorporate individual variation.
    Magn Reson Imaging. 2018;45:66-71.
    PubMed     Abstract available

    December 2017
  19. KARGAR S, Borisch EA, Froemming AT, Kawashima A, et al
    Robust and efficient pharmacokinetic parameter non-linear least squares estimation for dynamic contrast enhanced MRI of the prostate.
    Magn Reson Imaging. 2017 Dec 23. pii: S0730-725X(17)30297.
    PubMed     Abstract available

    November 2017
  20. PAPADOPOULOS I, Phillips J, Evans R, Fenn N, et al
    Evaluation of Diffusion Weighted Imaging in the Context of Multi-Parametric MRI of the Prostate in the assessment of suspected low volume prostatic carcinoma.
    Magn Reson Imaging. 2017 Nov 25. pii: S0730-725X(17)30263.
    PubMed     Abstract available

  21. WARNDAHL BA, Borisch EA, Kawashima A, Riederer SJ, et al
    Conventional vs. reduced field of view diffusion weighted imaging of the prostate: Comparison of image quality, correlation with histology, and inter-reader agreement.
    Magn Reson Imaging. 2017 Nov 2. pii: S0730-725X(17)30237.
    PubMed     Abstract available

    October 2017
  22. MAZAHERI Y, Hotker AM, Shukla-Dave A, Akin O, et al
    Model selection for high b-value diffusion-weighted MRI of the prostate.
    Magn Reson Imaging. 2017 Oct 11. pii: S0730-725X(17)30219.
    PubMed     Abstract available

    August 2017
  23. JIAN-YING X, Shan-Shan G, Jin-Gang L, Cheng-Feng S, et al
    The value of ESWAN in diagnosis and differential diagnosis of prostate cancer: Preliminary study.
    Magn Reson Imaging. 2017 Aug 3. pii: S0730-725X(17)30154.
    PubMed     Abstract available

    May 2017
  24. LUTTJE MP, van Buuren LD, Luijten PR, van Vulpen M, et al
    Towards intrinsic R2* imaging in the prostate at 3 and 7tesla.
    Magn Reson Imaging. 2017 May 4. pii: S0730-725X(17)30087.
    PubMed     Abstract available

    January 2017
  25. RIEDERER SJ, Borisch EA, Froemming AT, Grimm RC, et al
    Improved performance of prostate DCE-MRI using a 32-coil vs. 12-coil receiver array.
    Magn Reson Imaging. 2017 Jan 26. pii: S0730-725X(17)30024.
    PubMed     Abstract available

    July 2016
  26. SUBUDHI BN, Thangaraj V, Esakkirajan S, Ghosh A, et al
    Tumor or Abnormality Identification from Magnetic Resonance Images using Statistical Region Fusion based Segmentation.
    Magn Reson Imaging. 2016 Jul 28. pii: S0730-725X(16)30081.
    PubMed     Abstract available

    May 2016
  27. FEDOROV A, Tuncali K, Panych LP, Fairhurst J, et al
    Segmented Diffusion-Weighted Imaging of the Prostate: Application to Transperineal In-bore 3T MR Image-guided Targeted Biopsy.
    Magn Reson Imaging. 2016 May 27. pii: S0730-725X(16)30068.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Prostate Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.